{
    "id": 32676,
    "fullName": "PTPRB dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PTPRB dec exp indicates decreased expression of the Ptprb protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5787,
        "geneSymbol": "PTPRB",
        "terms": [
            "PTPRB",
            "HPTP-BETA",
            "HPTPB",
            "PTPB",
            "R-PTP-BETA",
            "VEPTP"
        ]
    },
    "variant": "dec exp",
    "createDate": "03/02/2020",
    "updateDate": "03/02/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4274,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells with decreased PTPRB expression via knockdown were sensitive to Sutent (sunitinib) in culture, resulting in inhibition of cellular characteristics related to angiogenesis (PMID: 24633157).",
            "molecularProfile": {
                "id": 35277,
                "profileName": "PTPRB dec exp"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 4450,
                    "pubMedId": 24633157,
                    "title": "Recurrent PTPRB and PLCG1 mutations in angiosarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24633157"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4275,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells with decreased PTPRB expression via knockdown were sensitive to Vatalanib (PTK787) in culture, resulting in inhibition of cellular characteristics related to angiogenesis (PMID: 24633157).",
            "molecularProfile": {
                "id": 35277,
                "profileName": "PTPRB dec exp"
            },
            "therapy": {
                "id": 3171,
                "therapyName": "Vatalanib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 4450,
                    "pubMedId": 24633157,
                    "title": "Recurrent PTPRB and PLCG1 mutations in angiosarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24633157"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35277,
            "profileName": "PTPRB dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}